What is the most likely cause of a rising blood urea nitrogen (BUN) in a patient with worsening liver function tests, a negative hepatitis work‑up, and no evidence of cholecystitis, and how should it be managed?

Rising BUN with Worsening Liver Function: Hepatorenal Syndrome Until Proven Otherwise

In a patient with rising BUN and worsening liver function tests (negative hepatitis panel, no cholecystitis), the most likely diagnosis is hepatorenal syndrome (HRS) or acute kidney injury (AKI) in the setting of decompensated cirrhosis, and you must immediately assess for volume status, exclude other causes of AKI, and consider urgent nephrology consultation.

Diagnostic Approach

Immediate Assessment Required

The combination of rising BUN with deteriorating liver function strongly suggests hepatorenal syndrome or AKI complicating advanced liver disease 1. This is a medical emergency requiring rapid evaluation:

• Check for ascites: Perform diagnostic paracentesis if ascites is present to rule out spontaneous bacterial peritonitis (SBP), which commonly precipitates HRS 1
• Assess volume status: Distinguish between prerenal azotemia (hypovolemia) versus HRS versus acute tubular necrosis
• Calculate SAAG: A gradient ≥1.1 g/dL confirms portal hypertension from liver disease 1
• Review medications: Stop nephrotoxic agents (NSAIDs, diuretics if volume depleted, aminoglycosides)

Key Diagnostic Considerations

Bile cast nephropathy is an important but less common cause when bilirubin is markedly elevated (>20 mg/dL). This condition occurs when severe hyperbilirubinemia causes direct tubular injury from bile pigment deposition 2. However, this typically requires extreme hyperbilirubinemia and may need kidney biopsy for definitive diagnosis.

The rising BUN in liver disease reflects multiple mechanisms:

• Hepatorenal syndrome: Functional renal failure from splanchnic vasodilation and renal vasoconstriction
• Volume depletion: From diuretics, lactulose, or poor oral intake
• Increased protein catabolism: Common in decompensated cirrhosis 3
• GI bleeding: Check BUN/Cr ratio; if >30, consider occult upper GI bleeding 4

Management Algorithm

Step 1: Exclude Reversible Causes

• Volume resuscitation: If hypovolemic, give albumin 1 g/kg (max 100g) to distinguish prerenal from HRS 1
• Treat infections aggressively: Check for SBP (PMN count >250 cells/mm³), urinary tract infection, pneumonia 1
• Stop diuretics temporarily if volume depleted
• Rule out obstruction: Bladder scan and renal ultrasound

Step 2: Classify AKI Stage

According to the 2021 AASLD guidance 1, use standardized AKI criteria:

• Stage 1: Creatinine increase ≥0.3 mg/dL or 1.5-2× baseline
• Stage 2: Creatinine 2-3× baseline
• Stage 3: Creatinine >3× baseline or ≥4.0 mg/dL

Step 3: Specific Interventions

For suspected HRS:

• Albumin plus vasoconstrictors: Midodrine/octreotide or terlipressin (if available) 1
• Avoid further diuretics until renal function stabilizes
• Consider TIPS if refractory ascites contributing
• Evaluate for liver transplantation urgently - simultaneous liver-kidney transplant may be needed 1

For bile cast nephropathy (if bilirubin >20 mg/dL):

• Hemodialysis may be required for severe cases 2
• Supportive care while treating underlying liver disease
• Kidney biopsy if diagnosis uncertain and would change management

Critical Pitfalls to Avoid

1. Don't assume prerenal azotemia: Fractional sodium excretion <1% is present in only a minority of cases with disproportionate BUN elevation 3. The presence of liver disease changes the interpretation.

2. Don't delay paracentesis: If ascites is present, diagnostic tap is mandatory to exclude SBP, which is present in 14/19 patients with severe azotemia in ICU settings 3 and commonly triggers HRS 1.

3. Don't overlook GI bleeding: A BUN/Cr ratio >30 has 89% specificity for upper GI bleeding 4. Even occult bleeding increases BUN through protein absorption.

4. Don't continue nephrotoxic medications: NSAIDs, aminoglycosides, and excessive diuretics worsen outcomes in this population 1.

5. Recognize multifactorial causes: Elderly patients with liver disease often have multiple contributors - hypovolemia, infection, high protein intake, and hypercatabolism 3. Address all simultaneously.

Prognostic Implications

Rising BUN in cirrhotic patients with ascites carries significant mortality risk. The BUN-to-albumin ratio independently predicts 30-day mortality (HR 1.03 per unit increase) 5, and each 1 mg/dL BUN rise increases mortality by 1% in critically ill patients 6. Early recognition and aggressive management are essential - mortality approaches 50% in patients developing hepatorenal syndrome without treatment 1.

The threshold effect occurs around BUN 32 mg/dL, above which mortality risk plateaus 7, but intervention should begin well before this point.